In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug regimen for clinical outcomes at 96 wk.
Ann Intern Med
; 176(6): JC64, 2023 06.
Article
em En
| MEDLINE
| ID: mdl-37276602
ABSTRACT
SOURCE CITATION Paton NI, Cousins C, Suresh C, et al; TRUNCATE-TB Trial Team. Treatment strategy for rifampin-susceptible tuberculosis. N Engl J Med. 2023;388873-887. 36808186.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tuberculose
/
Antituberculosos
Limite:
Humans
Idioma:
En
Revista:
Ann Intern Med
Ano de publicação:
2023
Tipo de documento:
Article